Biochemists' bliss: harnessing the power of snake toxins to treat cardiovascular diseases | Zendy

Cho Yeow Koh | Zendy; R. Manjunatha Kini | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Biochemists' bliss: harnessing the power of snake toxins to treat cardiovascular diseases

Author(s) -

Cho Yeow Koh,

R. Manjunatha Kini

Publication year - 2019

Publication title -

the biochemist

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.126

H-Index - 7

eISSN - 1740-1194

pISSN - 0954-982X

DOI - 10.1042/bio04106010

Subject(s) - snake venom , venom , viperidae , medicine , tirofiban , pharmacology , blood clotting , intensive care medicine , biology , ecology , percutaneous coronary intervention , myocardial infarction

Deadly snake venom can be turned into life-saving therapeutics. Currently, several medicinal agents approved by the US Food and Drug Administration originated from snake venom. These include captopril, used to treat high blood pressure, as well as eptifibatide and tirofiban, used as bloodthinning agents to prevent thrombosis (clotting of blood in the circulation). Many other snake venom toxins have also been made into reagents that help to diagnose different kinds of blood disorders. Here, we discuss the molecular basis of how snake venom affects components in blood to unveil secrets behind the deadly weapon that can be harnessed for its power of healing.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research